Pfizer Coronavirus Vaccine
-
{
- All
- News
- Videos
-
Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Moderna's Shot Creates Twice As Many Antibodies As Pfizer, Study Shows
Moderna Inc.'s Covid vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE in research directly comparing immune responses to the inoculations.
-
Israel Finds Probable Link Between Pfizer Covid Shot, Myocarditis
Israel health officials have found a probable link between Pfizer Inc. and BioNTech SE's coronavirus vaccine and dozens of cases of heart inflammation in young men following the second dose of the vaccine, the Health Ministry said late Tuesday.
-
Pfizer Says It Can Deliver 10% More Covid Vaccines By End Of May
Pfizer has "ramped up production" of its Covid-19 vaccine and can deliver 10 percent more doses than expected to the United States by the end of May, its CEO Albert Bourla said on Tuesday.
-
Pfizer, BioNTech Say Covid Vaccine Effective Against South African Variant
Pfizer and BioNTech said Thursday their Covid-19 vaccine was highly effective against the South African variant in the latest phase of ongoing clinical trials.
-
Pfizer Wants To Make Vaccine In India If Faster Clearance Assured: Report
Pfizer Inc has told the government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter told Reuters.
-
Pfizer Wants India To Order Covid Vaccine Before Pursuing Approval
Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday, even as global supplies tighten.
-
Pfizer Must Conduct Local Study For Vaccine Approval: Official
Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.
-
"Short Notice, Different Time Zone": Pfizer On Delay In Vaccine Approval
US pharma giant Pfizer, whose Covid vaccine has yet be approved, told NDTV on Monday that it had been "unable to participate in previous meetings (to present safety and efficacy data) due to extremely short notice" and time zone differences
-
US Nurse Tests Positive Over A Week After Receiving Pfizer Vaccine: Report
A 45-year-old nurse in California tested positive for COVID-19 more than a week after receiving Pfizer Inc's coronavirus vaccine, an ABC News affiliate reported on Tuesday.
-
Switzerland Says Pfizer Covid Vaccine "Safe", Approves For Use
The Pfizer/BioNTech vaccine has been authorised for use in Switzerland following a two-month rolling review, the Swissmedic regulatory authority said Saturday.
-
US Drug Regulator Investigating 5 Allergic Reactions After Pfizer Shot
The US Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE's COVID-19 vaccine in the United States this week, a top FDA official said late on Friday.
-
Pfizer Covid Vaccine Gets US Experts' Nod For Emergency Use Approval
An expert committee convened by the US Food and Drug Administration voted heavily in favor of recommending the Pfizer-BioNTech Covid-19 vaccine for emergency use approval on Thursday.
-
What Pfizer Said On Key Challenge In Coronavirus Vaccine Storage In India
American pharmaceutical firm Pfizer, which has asked the DCGI (Drugs Controller General of India) for emergency approval of its coronavirus vaccine, has said it is prepared to address a key challenge in the distribution of its vaccine - ultra-cold storage.
-
Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Moderna's Shot Creates Twice As Many Antibodies As Pfizer, Study Shows
Moderna Inc.'s Covid vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE in research directly comparing immune responses to the inoculations.
-
Israel Finds Probable Link Between Pfizer Covid Shot, Myocarditis
Israel health officials have found a probable link between Pfizer Inc. and BioNTech SE's coronavirus vaccine and dozens of cases of heart inflammation in young men following the second dose of the vaccine, the Health Ministry said late Tuesday.
-
Pfizer Says It Can Deliver 10% More Covid Vaccines By End Of May
Pfizer has "ramped up production" of its Covid-19 vaccine and can deliver 10 percent more doses than expected to the United States by the end of May, its CEO Albert Bourla said on Tuesday.
-
Pfizer, BioNTech Say Covid Vaccine Effective Against South African Variant
Pfizer and BioNTech said Thursday their Covid-19 vaccine was highly effective against the South African variant in the latest phase of ongoing clinical trials.
-
Pfizer Wants To Make Vaccine In India If Faster Clearance Assured: Report
Pfizer Inc has told the government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter told Reuters.
-
Pfizer Wants India To Order Covid Vaccine Before Pursuing Approval
Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday, even as global supplies tighten.
-
Pfizer Must Conduct Local Study For Vaccine Approval: Official
Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.
-
"Short Notice, Different Time Zone": Pfizer On Delay In Vaccine Approval
US pharma giant Pfizer, whose Covid vaccine has yet be approved, told NDTV on Monday that it had been "unable to participate in previous meetings (to present safety and efficacy data) due to extremely short notice" and time zone differences
-
US Nurse Tests Positive Over A Week After Receiving Pfizer Vaccine: Report
A 45-year-old nurse in California tested positive for COVID-19 more than a week after receiving Pfizer Inc's coronavirus vaccine, an ABC News affiliate reported on Tuesday.
-
Switzerland Says Pfizer Covid Vaccine "Safe", Approves For Use
The Pfizer/BioNTech vaccine has been authorised for use in Switzerland following a two-month rolling review, the Swissmedic regulatory authority said Saturday.
-
US Drug Regulator Investigating 5 Allergic Reactions After Pfizer Shot
The US Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE's COVID-19 vaccine in the United States this week, a top FDA official said late on Friday.
-
Pfizer Covid Vaccine Gets US Experts' Nod For Emergency Use Approval
An expert committee convened by the US Food and Drug Administration voted heavily in favor of recommending the Pfizer-BioNTech Covid-19 vaccine for emergency use approval on Thursday.
-
What Pfizer Said On Key Challenge In Coronavirus Vaccine Storage In India
American pharmaceutical firm Pfizer, which has asked the DCGI (Drugs Controller General of India) for emergency approval of its coronavirus vaccine, has said it is prepared to address a key challenge in the distribution of its vaccine - ultra-cold storage.
